News - Townsend Investments
LATEST NEWS:
11th May 2016 - NovaBiotics to Present Exciting New Data at ECFS 2016

NOVABIOTICS TO PRESENT EXCITING NEW DATA AT ECFS 2016
PRESENTATIONS ON THE APPLICATION OF LYNOVEX AND NOVAMYCIN IN CYSTIC FIBROSIS
NovaBiotics scientific team will be in force and very busy in Basel at ECFS http://www.ecfs.eu/basel2016, Europe’s key cystic fibrosis conference, with e-poster talks and posters being presented on Lynovex’s potential use against Burkholderia Spp in CF [ePS06.2 14:00-15:00, 10th June 2016] and the use of novel inhaled formulations of Lynovex (cysteamine) in CF [ePS03.5 14:00-15:00, 9th June 2016] and the application of our novel antifungal Novamycin against emerging fungal infections associated with CF [ePS03.9 14:00-15:00, 9th June 2016]



Go Back